Some weeks show no loss despite perfect adherence
It is an investigational triple-receptor agonist that simultaneously targets the GLP-1, GIP, and glucagon receptors pathways involved in glucose regulation, energy balance, and metabolic homeostasis
Short-acting preparations include beinaglutide (BN) and exenatide (EX), which generally need to be injected 2-3 times a day
Animal experiments The adult female Sprague-Dawley (SD) rats (about 160 g, 6 weeks old), SD juvenile rats (50100 g, about 24 weeks old) and SD neonatal rats (2040 g, about 12 weeks old) used in the experiment were purchased from the Laboratory Animal Center of Army Medical University
Ann Intern Med [Internet]
The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy